258 related articles for article (PubMed ID: 34190575)
1. Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
Ast V; Costina V; Eichner R; Bode A; Aida S; Gerhards C; Thiaucourt M; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M; Haselmann V
J Clin Microbiol; 2021 Aug; 59(9):e0055921. PubMed ID: 34190575
[TBL] [Abstract][Full Text] [Related]
2. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
Haselmann V; Özçürümez MK; Klawonn F; Ast V; Gerhards C; Eichner R; Costina V; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M
Clin Chem Lab Med; 2020 Aug; 58(12):2121-2130. PubMed ID: 32853163
[TBL] [Abstract][Full Text] [Related]
3. Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.
Kittel M; Eichner R; Aida S; Bode A; Ast V; Kessler A; Neumaier M; Wölfel R; Haselmann V
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016287
[TBL] [Abstract][Full Text] [Related]
4. External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021.
Mögling R; Colavita F; Reimerink J; Melidou A; Leitmeyer K; Keramarou M; Lapa D; Francalancia M; Murk JL; Vossen A; Carletti F; Hogema B; Meijer A; Deprez L; di Caro A; Castilletti C; Reusken CB
Euro Surveill; 2022 Oct; 27(42):. PubMed ID: 36268736
[TBL] [Abstract][Full Text] [Related]
5. Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme.
Sciacovelli L; Padoan A; Secchiero S; Plebani M
Clin Chem Lab Med; 2021 Oct; 59(11):1878-1884. PubMed ID: 34348424
[TBL] [Abstract][Full Text] [Related]
6. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
7. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
10. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
[TBL] [Abstract][Full Text] [Related]
11. First Results of an External Quality Assessment (EQA) Scheme for Molecular, Serological and Antigenic Diagnostic Test for SARS-CoV-2 Detection in Lombardy Region (Northern Italy), 2020-2022.
Pasotti F; Pellegrinelli L; Liga G; Rizzetto M; Azzarà G; Da Molin S; Lungu OL; Greco S; Galli C; Bubba L; Pariani E; Corradin M; Cereda D; Buoro S
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741293
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
13. [Evaluation of the Diagnostic Performance of Different Principles of SARS-CoV-2 Commercial Antibody Tests in COVID-19 Patients].
Dinç HÖ; Özdemir YE; Alkan S; Güngördü Dalar Z; Gareayaghi N; Sirekbasan S; Tuyji Tok Y; Kuşkucu MA; Karaali R; Özbey D; Aygün G; Midilli K; Kocazeybek B
Mikrobiyol Bul; 2021 Apr; 55(2):207-222. PubMed ID: 33882652
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
[TBL] [Abstract][Full Text] [Related]
16. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
[TBL] [Abstract][Full Text] [Related]
17. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
[TBL] [Abstract][Full Text] [Related]
18. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
[TBL] [Abstract][Full Text] [Related]
19. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.
Jiang JC; Zhang Y
Biochem Soc Trans; 2020 Dec; 48(6):2851-2863. PubMed ID: 33170924
[TBL] [Abstract][Full Text] [Related]
20. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
Guo CC; Mi JQ; Nie H
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
